SB-315021
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Enzyme inhibitors |
| Catalog number | BBF-03404 |
| CAS | |
| Molecular Weight | 554.7 |
| Molecular Formula | C28H46N2O9 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
SB-315021 is an inhibitor of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579.
- Specification
- Properties
- Reference Reading
- Price Product List
| Synonyms | SB 315021; SB315021 |
| IUPAC Name | N-(1,5-dioxo-5a,6,7,8-tetrahydropyrrolo[1,2-c][1,3]oxazepin-3-yl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxytetradecanamide |
| Canonical SMILES | CCCCCCCCCCCC(CC(=O)NC1=CC(=O)C2CCCN2C(=O)O1)OC3C(C(C(C(O3)C)O)O)O |
| InChI | InChI=1S/C28H46N2O9/c1-3-4-5-6-7-8-9-10-11-13-19(38-27-26(35)25(34)24(33)18(2)37-27)16-22(32)29-23-17-21(31)20-14-12-15-30(20)28(36)39-23/h17-20,24-27,33-35H,3-16H2,1-2H3,(H,29,32)/t18-,19?,20?,24-,25+,26+,27-/m0/s1 |
| InChI Key | WAHMOFCRXZFEQB-KITPZMISSA-N |
| Appearance | Off-white Powder |
1. SB-253514 and analogues: novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. II. Physico-chemical properties and structure elucidation
D J Busby, R C Copley, J A Hueso, S A Readshaw, A Rivera J Antibiot (Tokyo). 2000 Jul;53(7):670-6.
A series of novel inhibitors of lipoprotein associated phospholipase A2 were isolated from the culture broths of Pseudomonas fluorescens strain DSM11579. The inhibitors fall into two structurally isomeric classes each of which comprise compounds incorporating glycosylated hydrocarbon chains. The structure elucidation for the major member of each structural class is reported. The crystal structure of a non-glycosylated analogue of the 5,5-series, produced through biotransformation, is also reported.
| BBF-04621 | Artemisinin | Inquiry |
| BBF-05734 | Irofulven | Inquiry |
| BBF-00586 | Brefeldin A | Inquiry |
| BBF-03819 | Spinosyn A | Inquiry |
| BBF-03862 | Cefozopran hydrochloride | Inquiry |
| BBF-04727 | Strigolactone GR24 | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
